MDS Podcast
- Épisodes
- 339
- Parution
- plusieurs fois par semaine
- Dernier épisode
- 9 Nov 2026
À propos du podcast
Stay up to date on novel, clinically-relevant research findings in Parkinson's disease and other movement disorders. Each episode of the International Parkinson and Movement Disorder Society podcast discusses a relevant development in the field, including highlighted journal articles and interviews with the authors.
Épisodes 339
MDJ Research Article of the Year: Cognitive Phenotyping Via Digital Analysis of Spoken Word Properties
In this episode, Dr. Michele Matarazzo interviews Dr. Adolfo M. García, senior author of the MDJ Research Article of the Year in Movement Disorders. They discuss how automated analysis of verbal fluency tasks …
Notes de l’épisode
In this episode, Dr. Michele Matarazzo interviews Dr. Adolfo M. García, senior author of the MDJ Research Article of the Year in Movement Disorders. They discuss how automated analysis of verbal fluency tasks in 464 Spanish-speaking people with Parkinson's disease can predict global cognition and identify mild cognitive impairment more accurately than simple word counts, as well as the potential for brief, scalable digital cognitive assessments. Read the article.MDJ Review Article of the Year: Beyond Go and No-Go: Rethinking the Basal Ganglia
The classic direct and indirect pathways of the basal ganglia are often taught as simple “Go” and “No-Go” systems for movement. But emerging evidence reveals a much richer picture. Dr. Michele Matarazzo speaks …
Notes de l’épisode
The classic direct and indirect pathways of the basal ganglia are often taught as simple “Go” and “No-Go” systems for movement. But emerging evidence reveals a much richer picture. Dr. Michele Matarazzo speaks with Dr. Ann Graybiel about her 2026 Review Article of the Year Paper in Movement Disorders, exploring how basal ganglia circuits contribute to learning, decision-making, motivation, and mood; the emerging role of the external globus pallidus; and newly identified striosomal pathways that regulate dopamine and may reshape our understanding of Parkinson’s disease and other movement disorders. Read the article.MDJ Research Article of the Year: Cognitive Phenotyping Via Digital Analysis of Spoken Word Properties
Default Description for Episode
Hot Topic: Environmental toxicants and their role in Parkinson's disease
Dr. Ray Dorsey passionately shares the mounting evidence supporting the role environmental neuro-toxicants have in the development of Parkinson's disease (PD) and why PD prevention deserves our attention. Read …
Notes de l’épisode
Dr. Ray Dorsey passionately shares the mounting evidence supporting the role environmental neuro-toxicants have in the development of Parkinson's disease (PD) and why PD prevention deserves our attention. Read the article.Functional Movement Disorders | Congress 2026
Ms. Nicole Duff discusses with Dr. Sara Lidstone the diagnosis and management of functional neurological and movement disorders, including clinical signs, patient-centered communication, and the importance of …
Notes de l’épisode
Ms. Nicole Duff discusses with Dr. Sara Lidstone the diagnosis and management of functional neurological and movement disorders, including clinical signs, patient-centered communication, and the importance of interdisciplinary rehabilitation.AI and Wearable Devices: Potential and Pitfalls | Congress 2026
Dr. Mitra Afshari discusses with Dr. Jeffrey Hausdorff the potential of AI-enabled digital biomarkers in Parkinson’s disease, including their role in patient monitoring, challenges in accuracy and reliability …
Notes de l’épisode
Dr. Mitra Afshari discusses with Dr. Jeffrey Hausdorff the potential of AI-enabled digital biomarkers in Parkinson’s disease, including their role in patient monitoring, challenges in accuracy and reliability, and barriers to clinical implementation.Updates in Huntington's Disease | Congress 2026
Dr. Eduardo de Pablo-Fernández discusses with Dr. Samuel Kim recent advances in Huntington’s disease, including genetic mechanisms, emerging biomarkers, and the potential of huntingtin-lowering therapies and …
Notes de l’épisode
Dr. Eduardo de Pablo-Fernández discusses with Dr. Samuel Kim recent advances in Huntington’s disease, including genetic mechanisms, emerging biomarkers, and the potential of huntingtin-lowering therapies and gene therapy.Focused ultrasound | Congress 2026
Dr. Mitra Afshari discusses with Dr. Raul Martínez-Fernández recent advances in MRI-guided focused ultrasound for essential tremor and Parkinson’s disease, including improvements in safety and efficacy, its …
Notes de l’épisode
Dr. Mitra Afshari discusses with Dr. Raul Martínez-Fernández recent advances in MRI-guided focused ultrasound for essential tremor and Parkinson’s disease, including improvements in safety and efficacy, its relationship with deep brain stimulation, and emerging neuromodulation approaches.Understanding Frailty in Parkinsonism | Congress 2026
Ms. Nicole Duff discusses with Dr. Alison Yarnall the prevalence and impact of frailty in Parkinsonism, including how it is identified and measured and its implications for clinical trials and patient care.
PD biomarkers | Congress 2026
Dr. Eduardo de Pablo-Fernández discusses with Prof. Tom Foltynie emerging disease-modifying and restorative treatments for Parkinson’s disease, including recent clinical trial findings and promising therapeutic …
Notes de l’épisode
Dr. Eduardo de Pablo-Fernández discusses with Prof. Tom Foltynie emerging disease-modifying and restorative treatments for Parkinson’s disease, including recent clinical trial findings and promising therapeutic approaches.Updates in MSA | Congress 2026
Prof. Wassilios Meissner discusses scientific advances in multiple system atrophy, from our growing understanding of MSA pathophysiology to potential diagnostic biomarkers to investigational therapeutics.
Parkinson's disease genetics: What's new | Congress 2026
Dr. Ignacio Mata discusses with Dr. Divyani Garg the dramatic increases in genetic testing globally over the last several years that have enhanced our understanding of the genetic architecture of Parkinson's disease.
LRRK2 pathways in PD | Congress 2026
Dr. Sabine Hilfiker addresses with Dr. Tiago Outeiro the slight differences of alpha-synuclein pathology in LRRK PD and what they could mean in terms of cell biology and molecular mechanisms.
Autoimmune movement disorders | Congress 2026
Dr. Jerome Honnorat sits down with host Dr. Divyani Garg at the 2026 MDS international Congress to review the most recent advancements in autoimmune movement disorders.
Neuroimaging for Movement Disorders | Congress 2026
Dr. Cecilia Peralta sits down with host Dr. Michele Matarazzo to review the most recent findings and future of neuroimaging in the field.
An interview with the MDS President | Congress 2026
Prof. Burn speaks with Dr. Michele Matarazzo about the initiaves and direction of MDS.
What you missed: 2026 MDS Congress, Day 4
Dr. Genko Oyama gives us an inside look at the most exciting moments from the last full day of the MDS Congress — including 2 exciting Clinical Breakthrough announcements and his favorite case from the Video Challenge.
What you missed: 2026 MDS Congress, Day 3
Dr. Andrew Siderowf shares what you missed from #mdscongress day three, which included a deep dive into the evolving AI landscape and insightful live patient rounds.
What you missed: 2026 MDS Congress, Day 1
Dr. Thomas Kimber breaks down the eventful and science-packed first day of the #MDSCongress.
What you missed: 2026 MDS Congress, Day 2
Highlights from day 2: Dr. Sanjay Pandey recaps the key takeaways, including from the aging & comorbidities and renown awardee lecture sessions.
Presidential Lecture Awardee: David Marsden Lecture Award | Congress 2026
Prof. Tiago Outeiro speaks with 2026 MDS Congress C. David Marsden Presidential Lecture Award winner Prof. Vincenzo Bonifati about his landmark genetic discoveries and the future of movement disorders research.
Junior Awardee: Prevalence of Parkinson's in Kenya | Congress 2026
Sara Schaefer speaks with the MDS Congress 2026 Junior Award Winner Dr. Richard Morton about his prevalence study on Parkinson's disease in Kalifi County, Kenya, a substudy of the Transforming Parkinson's Care …
Notes de l’épisode
Sara Schaefer speaks with the MDS Congress 2026 Junior Award Winner Dr. Richard Morton about his prevalence study on Parkinson's disease in Kalifi County, Kenya, a substudy of the Transforming Parkinson's Care in Africa (TraPCAf) study.Junior Awardee: Can cortical signals tell us what is happening in the deep brain? | Congress 2026
In this episode, we speak with Zixiao Yin, recipient of a Junior Award at the MDS Congress, about his work on reconstructing deep brain activity from cortical signals. Using more than 700 hours of simultaneous …
Notes de l’épisode
In this episode, we speak with Zixiao Yin, recipient of a Junior Award at the MDS Congress, about his work on reconstructing deep brain activity from cortical signals. Using more than 700 hours of simultaneous cortical and subcortical recordings across different movement disorders, brain targets, and clinical states, Yin and colleagues developed deep learning approaches to infer subcortical activity from cortical recordings. We discuss why this could matter for adaptive DBS, how cortical signals can be used to estimate STN beta activity and reconstruct deep brain signals, and whether this approach could provide an alternative when direct subcortical sensing is unreliable.Presidential Lecture Awardee: Stanley Fahn Award Lecture | Congress 2026
Dr. Sara Schaefer speaks with 2026 MDS Congress Stanley Fahn Award Lecture winner Dr. Beomseok Jeon about his career and the inspiration he drew from his time as a movement disorders fellow under Dr. Stanley Fahn.
Setting the TEMPO: What have we learned about D1/D5 dopamine stimulation in Parkinson’s disease?
Dr. Divyani Garg speaks with Dr. Hubert H. Fernandez about tavapadon, a once-daily selective dopamine D1/D5 receptor agonist, and what the TEMPO clinical development program tells us about its potential role in …
Notes de l’épisode
Dr. Divyani Garg speaks with Dr. Hubert H. Fernandez about tavapadon, a once-daily selective dopamine D1/D5 receptor agonist, and what the TEMPO clinical development program tells us about its potential role in Parkinson’s disease (PD). They discuss the rationale for D1/D5 stimulation, findings from other TEMPO programs, the magnitude and clinical meaning of the motor benefit, flexible dosing, and the important tolerability and discontinuation findings from TEMPO-2. The conversation also explores where tavapadon might fit relative to levodopa and conventional D2/D3 dopamine agonists, and its potential role across different stages of PD. Read the article.History of Movement Disorders: Animal models for studying Parkinson's disease
Prof. Jeffrey Kordower and Prof. Franziska Richter Assêncio join Prof. Tiago Outeiro to discuss the historical use of animal models in the field of Parkinson's disease. Together they review ethical issues, the …
Notes de l’épisode
Prof. Jeffrey Kordower and Prof. Franziska Richter Assêncio join Prof. Tiago Outeiro to discuss the historical use of animal models in the field of Parkinson's disease. Together they review ethical issues, the value of different types of models, and their relevance to the field.Hot Topic: Prodromal Parkinson's disease
In this new episode of the Hot Topic 'Prodromal synucleinopathies' Dr. Eva Schäffer joins Dr. Eduardo de Pablo Fernández to discuss recent advances, future challenges, and practical clinical advice in …
Notes de l’épisode
In this new episode of the Hot Topic 'Prodromal synucleinopathies' Dr. Eva Schäffer joins Dr. Eduardo de Pablo Fernández to discuss recent advances, future challenges, and practical clinical advice in prodromal Parkinson's disease.What is it? A young girl with subacute jerky movements
In this episode, Dr. Kathryn Yang discusses a case of a young girl with subacute-onset jerky movements with an interesting finding on oculomotor examination, and explores the etiological diagnosis of this …
Notes de l’épisode
In this episode, Dr. Kathryn Yang discusses a case of a young girl with subacute-onset jerky movements with an interesting finding on oculomotor examination, and explores the etiological diagnosis of this peculiar syndrome. Read the article.Hot Topic: Prodromal synucleinopathies - REM sleep behaviour disorder
Sleep Specialist Dr. Laura Pérez-Carbonell joins Dr. Eduardo de Pablo Fernández to discuss a wide range of topics related to REM sleep behaviour disorder as a prodromal synucleinopathy.
ERNA: A newer neurophysiological biomarker to automate DBS programming
In this episode, Dr. Mitra Afshari speaks with Dr. Jen Nagao about her latest work highlighting the automation of subthalamic deep brain stimulation (DBS) with Evoked Resonant Neural Activity (ERNA) in …
Notes de l’épisode
In this episode, Dr. Mitra Afshari speaks with Dr. Jen Nagao about her latest work highlighting the automation of subthalamic deep brain stimulation (DBS) with Evoked Resonant Neural Activity (ERNA) in Parkinson’s disease. They discuss the potential benefits of ERNA over beta power in the operating room and future opportunities to explore this newer neurophysiological marker for DBS programming. Read the article. Journal CME is available until June 30, 2027.
Voici les 40 derniers épisodes sur 339. Les épisodes plus anciens se trouvent dans le flux du podcast.
Podcasts similaires
Plus de podcasts : Sciences
C’est votre podcast ?
Confirmez-le avec une entrée dans votre flux : vous recevez ici un code, vous l’ajoutez comme podcast:txt dans le canal de votre flux, et nous le vérifions. Votre podcast apparaît ensuite comme « vérifié » sur SoundNode.